BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11560954)

  • 1. Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.
    Milella M; Kornblau SM; Estrov Z; Carter BZ; Lapillonne H; Harris D; Konopleva M; Zhao S; Estey E; Andreeff M
    J Clin Invest; 2001 Sep; 108(6):851-9. PubMed ID: 11560954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells.
    Dai Y; Yu C; Singh V; Tang L; Wang Z; McInistry R; Dent P; Grant S
    Cancer Res; 2001 Jul; 61(13):5106-15. PubMed ID: 11431348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
    Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
    Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia.
    Milella M; Estrov Z; Kornblau SM; Carter BZ; Konopleva M; Tari A; Schober WD; Harris D; Leysath CE; Lopez-Berestein G; Huang Z; Andreeff M
    Blood; 2002 May; 99(9):3461-4. PubMed ID: 11964319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
    Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling.
    Morgan MA; Dolp O; Reuter CW
    Blood; 2001 Mar; 97(6):1823-34. PubMed ID: 11238126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
    Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
    Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis.
    Wu J; Wong WW; Khosravi F; Minden MD; Penn LZ
    Cancer Res; 2004 Sep; 64(18):6461-8. PubMed ID: 15374955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of MEK signaling enhances the ability of cytarabine to induce growth arrest and apoptosis of acute myelogenous leukemia cells.
    Nishioka C; Ikezoe T; Yang J; Yokoyama A
    Apoptosis; 2009 Sep; 14(9):1108-20. PubMed ID: 19548087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts.
    Lunghi P; Tabilio A; Dall'Aglio PP; Ridolo E; Carlo-Stella C; Pelicci PG; Bonati A
    Leukemia; 2003 Sep; 17(9):1783-93. PubMed ID: 12970778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells.
    Bhatia N; Agarwal C; Agarwal R
    Nutr Cancer; 2001; 39(2):292-9. PubMed ID: 11759294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate.
    Gazitt Y; Reddy SV; Alcantara O; Yang J; Boldt DH
    J Cell Physiol; 2001 Apr; 187(1):124-35. PubMed ID: 11241357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-activated protein kinase kinase inhibition enhances nuclear proapoptotic function of p53 in acute myelogenous leukemia cells.
    Kojima K; Konopleva M; Samudio IJ; Ruvolo V; Andreeff M
    Cancer Res; 2007 Apr; 67(7):3210-9. PubMed ID: 17409429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
    Barata JT; Silva A; Brandao JG; Nadler LM; Cardoso AA; Boussiotis VA
    J Exp Med; 2004 Sep; 200(5):659-69. PubMed ID: 15353558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma inhibits hepatocyte growth factor-stimulated cell proliferation of human bronchial epithelial cells: upregulation of p27(kip1) cyclin-dependent kinase inhibitor.
    Takami K; Takuwa N; Okazaki H; Kobayashi M; Ohtoshi T; Kawasaki S; Dohi M; Yamamoto K; Nakamura T; Tanaka M; Nakahara K; Takuwa Y; Takizawa H
    Am J Respir Cell Mol Biol; 2002 Feb; 26(2):231-8. PubMed ID: 11804875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression.
    Qiao L; Leach K; McKinstry R; Gilfor D; Yacoub A; Park JS; Grant S; Hylemon PB; Fisher PB; Dent P
    Hepatology; 2001 Nov; 34(5):906-17. PubMed ID: 11679961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.